HCCM leads Series A round for PierianDx
St. Louis, Missouri-based PierianDx, a genomic software provider, has raised $9.25 million in Series A funding. Health Catalyst Capital Management led the round.
7 January 2016•2 mins read
St. Louis, Missouri-based PierianDx, a genomic software provider, has raised $9.25 million in Series A funding. Health Catalyst Capital Management led the round.
